Development of a Biological Database in the Field of Operative Intensive Care
ConditionIntensive Care in General
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRWTH Aachen University
About this trial
The storage and use of biomaterial samples is an important requirement for accompanying research and the acquisition of new knowledge to improve prognosis and therapy. Biobanking is explicitly recommended in official guidelines. In order to preserve the biomaterial, the patient must consent to the removal, transfer and storage of the biomaterial separately from the consent to the register. The biomaterial is taken at times at which a blood or urine sampling takes place anyway in the clinical routine. Therefore no additional interventions are necessary.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients after admission to the intensive care unit
18 years or older
signed informed consent
Disqualifiers
No exclusion criteria are formulated with regard to the objective of the register to record intensive care patients in general. Patients with multiple comorbidities, organ dysfunctions, and non-compliance for a curatively-intended therapy should also be recorded in the register. A palliative treatment or decision for best supportive care is not an exclusion criterion for registering.
Trial population
intensive care patients in general
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Biological Database
Other interventionBiological Database
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Interleukin 6 value [nmol/l]
Record of clinically relevant parameters
Time frame
10 days2
Interleukin 10 [nmol/l]
Record of clinically relevant parameters
Time frame
10 days3
Adrenomedullin value [nmol/l]
Record of clinically relevant parameters
Time frame
10 days4
Tumornekrosefaktor alpha [nmol/l]
Record of clinically relevant parameters
Time frame
10 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov